PCG Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,507
Closed -$712K – 129
2026
Q2
$712K Sell
5,507
-80
-1% -$9.36K 0.51% 46
2026
Q1
$677K Sell
5,587
-60
-1% -$6.93K 0.54% 46
2025
Q4
$600K Sell
5,647
-200
-3% -$18.8K 0.48% 48
2025
Q3
$491K Sell
5,847
-160
-3% -$13.2K 0.39% 53
2025
Q2
$476K Sell
6,007
-86
-1% -$6.84K 0.41% 53
2025
Q1
$547K Buy
6,093
+30
+0.5% +$2.8K 0.51% 50
2024
Q4
$603K Buy
+6,063
New +$625K 0.53% 46

Other funds holding MRK

PCG Asset Management's MRK Position: Q3 2026 in Review

PCG Asset Management sold out of Merck (MRK) in Q3 2026, closing a stake of 5,507 shares — an estimated $712K sold.

PCG Asset Management first reported a position in MRK in Q4 2024 and held it in 7 quarters. The position peaked at $712K in Q2 2026. 3,953 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • PCG Asset Management reported no remaining Merck position as of Q3 2026 after selling out during the quarter.
  • PCG Asset Management sold 5,507 Merck shares in Q3 2026, an estimated $712K.
  • PCG Asset Management first reported a position in Merck in Q4 2024 and held it in 7 quarters.
  • PCG Asset Management's Merck position peaked at $712K in Q2 2026.
  • 3,953 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on PCG Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.